Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
Ideas To Curb Surprise Medical Bills Percolate With Rare Bipartisan Push
The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Trump Zeroes In On Surprise Medical Bills In White House Chat With Patients, Experts
Patients and doctors got a chance to share their nightmarish experiences with medical bills with President Donald Trump and other top White House officials.
Democrats Winning Key Leadership Jobs Have Taken Millions From Pharma
Top House Republican also received more than $1 million from drugmakers since 2007.
Mujeres aplauden la decisión de Michelle Obama de hablar de su aborto espontáneo
En su libro de memorias, la ex primera dama relata la dolorosa experiencia que tuvieron que vivir con Barack Obama al perder un embarazo.
Women Applaud Michelle Obama’s Decision To Share Her Trauma Of Miscarriage
The attention may help women understand that miscarriage is common but still not easily talked about.
In Swing Districts, Republicans May Pay For Having Tried To Reverse The Health Law
Though Rep. Tom MacArthur counts himself a moderate, many of his voters heading to the polls are furious about how he aided his party’s efforts to dismantle Obamacare.
Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus
Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, members of Congress have received nearly $79 million from 68 pharma PACs. And the giving crosses the aisle: In California, seven of the top 10 beneficiaries are Democrats — though Kevin McCarthy, the Republican House majority leader, tops other Golden State lawmakers in Congress by a wide margin.
